Multiple Key Updates & Big Runners

Medigus, Ltd. MDGS – News Alert:

We’ve got more fresh news hitting the wires this morning from MDGS. One of the things we like best about the company is the frequency with which it communicates with its shareholders.

Today’s release pertains to the hiring of an advisory firm to guide Polyrizon, in which Medigus is a stakeholder, toward FDA approval for its nasal gels which are preventative against viruses, including COVID-19 and the flu.

Tel Aviv, Israel, Oct. 22, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Polyrizon Ltd., (37.01%), that it has engaged with a full-service Contract Research Organisation (CRO), to advise the Company in its pursuit of Food and Drug Administration (FDA) submission for its products. (>>View Full PR)


Watchlist Updates: 

We typically encourage our readers to keep track of not only the featured items in our daily reports, but our ‘Extended Watchlists’ as well. They often include hidden opportunities waiting to be unearthed.

Such was the case yesterday with DWAC, which was included in our premarket report before exploding from a daily low of 12.62 up as high as 52.00. That works out to an intraday run of 312%  Our overall observed range has increased already this morning with a premarket high of 93.43, which marks a rise of 640%

We also signaled MGTI on Monday morning, and it has posted a solid intraweek performance thus far. The stock came up from a low of .041  to a high of .064, an increase of 58%


Options Recap: 

Last but not least, we went three for three on options ideas in yesterday’s report, which provided the following intraday gain opportunities for our readers:

CSX Weekly $34-36 Calls
$34: 
1.30-1.84 (+42%)
$35: .45-.90 (+100%)
$36: .05-.24 (+380%)
_____

BX Weekly $130-133 Calls
$130: 2.50-4.83 (+93%)
$131: 1.69-3.67 (+117%)
$132: .93-3.05 (+228%)
$133: .72-2.32 (+222%)
_____

T Weekly $25.50-26.50 Calls 
$25.50: .20-.34 (+70%)
$26: .15-.36 (+140%)
$26.50: .05-.11 (+120%)
_____

Fresh Options Ideas: 
STX Weekly $82.50-85 Calls
AXP Weekly $177.50-182.50 Calls


Extended Watchlist:
PHUN, CRTD, GROM, DATS, CZNI, SEGI, TONR, ASTI, NSAV, CIVX, CAGC

Torrent of Earnings Reporters Continues

Abbott Laboratories Inc. ABT – Options Recap:

ABT was among our targeted options plays in yesterday morning’s premarket report, and the company’s daily activity allowed for some solid options runs.

We were after the ABT Weekly $122-124 Calls in the wake of Abbott’s Q2 earnings drop, and thanks to a solid beat on both profits and and sales along with a lofty outlook for the remainder of the year, we saw the following multibag intraday moves from our selected target contract sets.

ABT Weekly $122-124 Calls

$122: 1.12-2.08 (+86%)
$123: .62-1.45 (+134%)
$124: .34-.85 (+150%)

We also had some NFLX Calls from Tuesday that underwent a massive dip and rip and posted the following numbers yesterday:

NFLX Weekly $635-640 Calls
$635:
 3.17-9.50 (+227%)
$640: 2.20-7.20 (+200%)
_____

Fresh Options Ideas: 

CSX Weekly $34-36 Calls
BX Weekly $130-133 Calls
T Weekly $25.50-26.50 Calls 


OTC Reviews:

We’ve also caught a couple of runners on the OTC Markets this week that we wanted to report on. We tagged initially BTZI on Monday, and LIGA yesterday morning, and they both yielded rapid results for us.

Bots Inc. BTZI

Initial Alert: Oct 18th
Range: .0795-.1749
Gained: +120%
_____

LIG Assets, Inc. LIGA

Initial Alert: Oct 20th
Range: .0069-.013
Gained: +88%


Extended Watchlist:
CBTC, GDET, BBBT, MWWC, WWDH, DWAC, HX, SESN, NXTP, JRJC, INND, BLDV, MGTI

Across-the-Board Options Sweep & More

A Solid Options Sweep:

We went all out in yesterday morning ‘s report with options ideas in four chains. We’re finally back into the swing of another earnings season and it feels great! We selected three off of the daily earnings calendar, and went with some SPY calls as well, and we were not disappointed in any regard.

All four of our designated targets saw appreciable intraday runs. Those were the SPY 10/20 $448-450 Calls, the NFLX Weekly $635-640 Calls, the TRV Weekly $155 Calls, and the STLD 11/19 $60-65 Calls. Some of the gains were rather modest, but they all went green for us, and here were their intraday ranges and total possible gains:

SPY 10/20 $448-450 Calls
$448: 
1.59-3.28 (+106%)
$449: 1.07-2.40 (+124%)
$450: .68-1.60 (+135%)
_____

NFLX Weekly $635-640 Calls
$635: 16.55-21.00 (+27%)
$640: 14.70-18.75 (+28%)
_____

TRV Weekly $155 Calls
$155: 4.15-5.50 (+33%)
_____

STLD 11/19 $60-65 Calls
$60: 3.20-5.70 (+78%)
$65: 1.15-2.62 (+95%)


Fresh Options Ideas: 
BIIB Weekly $270-275 Calls
ABT Weekly $122-124 Calls


Atea Pharmaceuticals, Inc. AVIR – Recap:

Also in yesterday morning’s report was a tag of AVIR, which gapped down hard in the the premarket and immediately set about filling that gap.

The stock traded in a daily range from a low of 10.76, cruised back to as high as 16.63 (+55%) and did so on massive volume to the tune of more than 34X the daily average. We will continue to track its activity under these interesting circumstances in upcoming sessions.


Extended Watchlist:
AITX, OZSC, SHMP, TONR, SEGI, MTRT, LIGA, RDUS, TRKA, CEI, LMDX